Subscribe to Newsletter

Glaucoma

Subspecialties Basic & Translational Research

On the KUSp of Neuroprotective Medicine

Novel compounds prevent disease progression in mouse models of glaucoma

Subspecialties Imaging & Diagnostics

Dr. Alex Huang receives Heidelberg Engineering’s Research Award 2016

Alex Huang, MD, PhD, is the winner of the Heidelberg Engineering Xtreme Research Award 2016 for his research on aqueous angiography and OCT structural analysis of outflow pathways. He received the award in a ceremony during ARVO’s Annual Meeting in Seattle.

Subspecialties Retina

10,000th SPECTRALIS hits the market

Heidelberg Engineering has reached an important corporate milestone with the 10,000th SPECTRALIS® diagnostic imaging platform, which has been delivered to a French retina specialist.

Subspecialties Basic & Translational Research

The Polymath Molecule

From cornea to retina, NGF’s regenerative and neuroprotective potential seems immense. What does the future hold for this versatile little neurotrophin?

Subspecialties Glaucoma

A Story of Graphene, Gold, Tear Film and Ocular Injury

| Roisin McGuigan

Ascorbic acid testing could provide fast information on the severity of ocular injuries and postsurgical complications at the point-of-care

Subspecialties Professional Development

The 2015 Innovation Awards Are Here

| Roisin McGuigan

Here, we recognize a year’s worth of innovation. Apps, IOLs, imagers, lasers, devices and drugs – the latest and greatest are all here. But which one came out on top this year?

Subspecialties Glaucoma

Thinking Ahead

| Sponsored by Santen Pharmaceuticals

Preserved glaucoma product use increases the probability that future glaucoma surgery will fail. Let’s examine the literature…

Business & Profession Retina

E-learning for SPECTRALIS Widefield Imaging Module now available

For doctors and other operators to get familiar with the Widefield Imaging Module, the Heidelberg Engineering Academy has recently launched an interactive video tutorial.

Subspecialties Cornea / Ocular Surface

Who Benefits from Preservative-Free Glaucoma Therapy?

| Sponsored by Santen Pharmaceuticals

Taking the time to talk with patients about the signs and symptoms of ocular surface disease and performing some quick assessments could ensure selection of the most appropriate therapy, and help improve patient outcomes

Subspecialties Glaucoma

Wireless Drug Dosing

| Roisin McGuigan

“Smart” nanowires deliver drugs on demand using an applied electromagnetic field

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.